RD-MI: Retrieved Drop-outs Multiple Imputation A reduction in body weight was observed with WEGOVY irrespective of age, sex, race, ethnicity, BMI at baseline, body weight (kg) at baseline, and level of renal function impairment
If you still have more weight to lose, we will evaluate what dosing you should continue on, and you can purchase another round of Semaglutide or Tirzepatide in order to continue the medication
Frequency : Consistency is key
Choose MeAgain if you want a GLP-1 dose routine connected to food, side effects, weight, and progress instead of dose tracking sitting alone in a separate medication-reminder app
Coordination with home glucose monitoring and lifestyle strategies
de Boer IH